Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Reorganization Creates Prominent Roles For Mercy Hospital's Spielberg, CDER's Autor

This article was originally published in The Pink Sheet Daily

Executive Summary

Commissioner Hamburg places drug, biologics, devices and tobacco centers under Steven Spielberg's directorate; Deborah Autor becomes deputy commissioner for global regulatory operations and policy.

You may also be interested in...



FDA Again Taps Compliance Director For Globalization Post

Howard Sklamberg, currently director of the CDER Office of Compliance, will take over the Office of Global Regulatory Operations and Policy after a year as CDER compliance office director.

FDA’s Potential Black Hole: House Investigates Departure Of Acting Head Of Medical Products Office

Energy and Commerce Committee letter states public information discrepancies raised questions about Leona Brenner-Gati’s status and “the circumstances surrounding her resignation.”

Innovative Drug Development: Kalydeco Provides A Paradigm, FDA’s Spielberg Says

The deputy commissioner detailed the steps involved in getting Vertex’s cystic fibrosis drug rapidly through the approval process and noted that FDA is working on innovative study designs and assessing how to better use diagnostics.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS072509

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel